PAVmed (PAVM) said Tuesday it regained compliance with Nasdaq's continued listing standards for primary equity securities.
The medical technology company said it received a notification on Friday from Nasdaq stating its securities will continue to be listed and traded on the stock exchange.
PAVmed will be under a mandatory panel monitor for one year, during which any failure to meet stockholders' equity requirements will trigger a delisting notice, requiring immediate action and possibly a new hearing, the company said.
Shares of PAVmed were up nearly 6% in recent Tuesday trading.
Price: 0.84, Change: +0.05, Percent Change: +5.95
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。